Terns Pharmaceuticals' lead molecules, TERN-701 and TERN-601, face stiff competition from established and more effective treatments in CML and obesity markets. TERN-701's advantage of food-independent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results